NCBiotech News

BioSkryb Genomics, a Durham developer of amplification tools for single-cell analysis, has signed an agreement with a Dutch company to expand distribution of BioSkryb’s genomic and multiomic technology in Europe.

Kincell Bio, a new company formed to develop and manufacture cell therapies for biotechnology companies, may be based in Florida, but it has North Carolina fingerprints all over it. 

Kincell, a contract development and manufacturing organization (CDMO), was spun out of Inceptor Bio of Morrisville and has raised $36 million in Series A venture capital led by Raleigh-based Kineticos Ventures. 

KaryoLogic, a karyotyping services company based in Durham, is teaming up with a French biotechnology company to test and analyze chromosomes in human stem cells.

The partnership with Stem Genomics of Montpellier, France, will allow KaryoLogic to offer a digital assay that can identify more than 90% of the most common genomic abnormalities found in human pluripotent stem cells, according to KaryoLogic.

ProKidney LLC, a Winston-Salem-based clinical-stage biotechnology company founded in 2015 and targeting chronic kidney disease (CKD) with a proprietary cell therapy, plans to create up to 330 jobs and establish a new manufacturing facility in Greensboro by 2027. 

North Carolina Agricultural and Technical State University and Merck (NYSE:MRK) announced a collaboration agreement today for Merck to build a biotechnology training center at Gateway Research Park’s South Campus in East Greensboro.

Merck will outfit the facility with the equipment and classroom spaces necessary to provide and enhance academic programming and training for biotechnology careers for North Carolina A&T students. A process laboratory will allow opportunities for students to put knowledge into practice in an advanced discovery setting.

North Carolina Gov. Roy Cooper was recognized June 6 at the 20th annual World Stem Cell Summit in Winston-Salem for his role in developing the life sciences.

Cooper received the Regenerative Medicine Action Leadership Award from the Regenerative Medicine Foundation, a non-profit organization that promotes the development of regenerative medicine to improve health and deliver cures.

The North Carolina Biotechnology Center awarded 87 grants and loans totaling $2,283,930 to universities, bioscience companies and non-profit organizations in the third quarter of its fiscal year.

The awards, made in January, February and March, will support life science research, technology commercialization and entrepreneurship throughout North Carolina. The funding will also help universities and companies attract follow-on funding from other sources.

StrideBio, a gene therapy company based in Research Triangle Park, has sold its intellectual property to Ginkgo Bioworks of Boston.

RTP's Greenlight Biosciences has received regulatory approval to begin the first phase 1/2 clinical trial of its COVID-19 vaccine candidate in Rwanda.

Imagine receiving a COVID-19 vaccine not from the jab of a needle and syringe but by slipping a thin, clear film smaller than a postage stamp inside your cheek or under your tongue and letting it dissolve.

Paris-based Cellectis has successfully dosed its first U.S. patient with its UCART22 allogeneic CAR T-cell therapy product candidate that it made in its new Raleigh facility.

RTP-based AskBio has signed a multi-year research collaboration and option agreement with Bay-area firm ReCode Therapeutics to develop gene-editing technology for driving new precision therapies.

RTP gene therapy startup Opus Genetics has acquired the rights to two pre-clinical product candidates to treat inherited retinal diseases from New Jersey biopharm company Iveric Bio.

The European Society of Gene and Cell Therapy has recognized North Carolina gene therapy pioneer and entrepreneur Jude Samulski, Ph.D., with its inaugural Founders Award.

Sheila Mikhail, CEO and co-founder of AskBio, and Marcia Eisenberg, Ph.D., senior vice president and chief scientific officer at the Labcorp, comprise 10% of the total class of "Fiercest Women in Life Sciences 2022."